Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business

Core Insights - Stryker has entered into a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, forming a new entity called VB Spine, LLC [1][2] - The transaction aims to enhance the focus and growth potential of the spinal implants business as an independent company [2][3] - VB Spine will have exclusive access to Stryker's Mako Spine and Copilot technologies for its spinal procedures, fostering a strategic partnership [2][3] Company Overview - Stryker is a global leader in medical technologies, impacting over 150 million patients annually with innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [5] - Viscogliosi Brothers is a family-owned investment firm focused on the neuro-musculoskeletal industry, having founded and grown 42 businesses across more than 80 countries since its establishment in 1999 [6] - Barings, LLC is a financial partner in this transaction, managing over $421 billion in assets as of December 31, 2024 [7] Transaction Details - The sale includes a binding offer to acquire Stryker's spinal implants business in France, pending employee consultations and regulatory requirements [3] - The transaction is expected to close in the first half of 2025, with both Stryker and VB Spine continuing to operate separately until then [3]